Plasma repaglinid koncentrationen faldt hurtigt og 4 timer efter administration var der kun lave stofkoncentrationer i plasma hos type 2- diabetes patienter.
Plasma repaglinide levels decreased rapidly, and low drug concentrations were seen in the plasma of type 2 diabetic patients 4 hours post-administration.